| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.963 | 0.001 | 0.963 | Farnesoid X receptor antagonist | 0.145 0.058 CHEMBL3544846 | ||
| 0.903 | 0.001 | 0.903 | Potassium channel (Ca-activated) blocker | |||
| 0.888 | 0.004 | 0.888 | Streptokinase A inhibitor | 0.588 0.018 CHEMBL1176 0.559 0.021 CHEMBL3544846 | ||
| 0.873 | 0.002 | 0.873 | Histone deacetylase SIRT2 inhibitor | |||
| 0.828 | 0.002 | 0.828 | Histone deacetylase class III inhibitor | |||
| 0.825 | 0.004 | 0.825 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.783 | 0.005 | 0.783 | HERG channel blocker | |||
| 0.768 | 0.004 | 0.768 | Cardiotonic | |||
| 0.749 | 0.007 | 0.749 | Angiogenesis inhibitor | |||
| 0.707 | 0.004 | 0.707 | Potassium channel blocker | 0.652 0.005 CHEMBL1176 0.352 0.032 CHEMBL3544846 | ||
| 0.69 | 0.004 | 0.69 | P-glycoprotein inhibitor | |||
| 0.658 | 0.007 | 0.757 | Immunomodulator | 0.757 0.005 CHEMBL1176 0.621 0.01 CHEMBL3544846 | CHEMBL1176 | |
| 0.647 | 0.001 | 0.647 | Lanosterol 14 alpha demethylase inhibitor | 0.156 0.01 CHEMBL1176 0.149 0.012 CHEMBL3544846 | ||
| 0.581 | 0.003 | 0.581 | Cyclin E inhibitor | |||
| 0.55 | 0.002 | 0.55 | Chemokine receptor agonist | |||
| 0.536 | 0.003 | 0.536 | Aromatase inhibitor | 0.136 0.015 CHEMBL1176 0.17 0.011 CHEMBL3544846 | ||
| 0.516 | 0.002 | 0.516 | CYP2A6 inhibitor | 0.111 0.031 CHEMBL1176 | ||
| 0.457 | 0.019 | 0.457 | Hypoxia-inducible factor 1 alpha inhibitor | 0.215 0.135 CHEMBL1176 0.287 0.072 CHEMBL3544846 | ||
| 0.427 | 0.003 | 0.427 | H+/K+-transporting ATPase inhibitor | |||
| 0.422 | 0.005 | 0.422 | Cell wall synthesis inhibitor | 0.189 0.035 CHEMBL1176 0.197 0.031 CHEMBL3544846 | ||
| 0.448 | 0.042 | 0.551 | GABA C receptor rho-3 antagonist | 0.523 0.02 CHEMBL1176 0.551 0.014 CHEMBL3544846 | CHEMBL3544846 | |
| 0.399 | 0.003 | 0.399 | Pregnane X receptor agonist | 0.165 0.032 CHEMBL1176 0.157 0.042 CHEMBL3544846 | ||
| 0.395 | 0.003 | 0.395 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.02 0.013 CHEMBL1176 0.024 0.012 CHEMBL3544846 | ||
| 0.376 | 0.002 | 0.376 | Potassium channel intermediate-conductance Ca-activated blocker | 0.101 0.008 CHEMBL1176 0.057 0.048 CHEMBL3544846 | ||
| 0.375 | 0.003 | 0.375 | Vasopressin 2 antagonist | |||
| 0.376 | 0.005 | 0.376 | Alpha 2b adrenoreceptor antagonist | |||
| 0.365 | 0.004 | 0.365 | Antidiuretic hormone antagonist | |||
| 0.358 | 0.001 | 0.358 | CXC chemokine 1 receptor antagonist | 0.054 0.03 CHEMBL3544846 | ||
| 0.349 | 0.004 | 0.349 | CXC chemokine receptor antagonist | |||
| 0.309 | 0.003 | 0.309 | Thromboxane synthase inhibitor | 0.063 0.023 CHEMBL1176 0.06 0.027 CHEMBL3544846 | ||
| 0.341 | 0.056 | 0.374 | Calcium channel activator | 0.374 0.036 CHEMBL1176 0.362 0.042 CHEMBL3544846 | CHEMBL1176 | |
| 0.29 | 0.014 | 0.29 | Antiadrenergic | |||
| 0.288 | 0.014 | 0.288 | Adrenaline antagonist | |||
| 0.273 | 0.01 | 0.273 | Alpha 2 adrenoreceptor antagonist | |||
| 0.268 | 0.01 | 0.268 | Chemokine receptor antagonist | |||
| 0.258 | 0.007 | 0.258 | CC chemokine receptor antagonist | |||
| 0.253 | 0.005 | 0.357 | Adrenaline uptake inhibitor | 0.357 0.004 CHEMBL1176 0.191 0.006 CHEMBL3544846 | CHEMBL1176 | |
| 0.24 | 0.01 | 0.24 | Alpha 2a adrenoreceptor antagonist | |||
| 0.287 | 0.062 | 0.287 | DNA damaging | |||
| 0.233 | 0.008 | 0.233 | Opioid kappa receptor antagonist | |||
| 0.217 | 0.004 | 0.217 | Substance P antagonist | 0.21 0.004 CHEMBL1176 0.064 0.01 CHEMBL3544846 | ||
| 0.271 | 0.059 | 0.271 | Hypolipemic | |||
| 0.353 | 0.148 | 0.441 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.441 0.067 CHEMBL1176 0.322 0.184 CHEMBL3544846 | CHEMBL1176 | |
| 0.214 | 0.01 | 0.305 | 5 Hydroxytryptamine uptake inhibitor | 0.305 0.006 CHEMBL1176 0.106 0.024 CHEMBL3544846 | CHEMBL1176 | |
| 0.236 | 0.043 | 0.31 | Nitric-oxide synthase stimulant | 0.294 0.013 CHEMBL1176 0.31 0.009 CHEMBL3544846 | CHEMBL3544846 | |
| 0.224 | 0.033 | 0.224 | Acetylcholine M1 receptor antagonist | 0.129 0.097 CHEMBL1176 0.127 0.099 CHEMBL3544846 | ||
| 0.246 | 0.077 | 0.287 | Superoxide dismutase inhibitor | 0.234 0.085 CHEMBL1176 0.287 0.055 CHEMBL3544846 | CHEMBL3544846 | |
| 0.169 | 0.003 | 0.169 | Geranylgeranyltransferase I inhibitor | |||
| 0.178 | 0.018 | 0.178 | Histamine H1 receptor antagonist | |||
| 0.172 | 0.012 | 0.172 | Alpha adrenoreceptor agonist | 0.149 0.016 CHEMBL1176 0.136 0.019 CHEMBL3544846 | ||
| 0.162 | 0.005 | 0.162 | Alpha 2 adrenoreceptor agonist | 0.146 0.007 CHEMBL1176 0.126 0.009 CHEMBL3544846 | ||
| 0.159 | 0.004 | 0.159 | Farnesyltransferase inhibitor | |||
| 0.159 | 0.004 | 0.159 | Potassium channel (Inward rectifier) blocker | |||
| 0.224 | 0.072 | 0.224 | EphB2 antagonist | |||
| 0.162 | 0.012 | 0.162 | Adrenaline agonist | 0.091 0.044 CHEMBL1176 0.147 0.015 CHEMBL3544846 | ||
| 0.153 | 0.005 | 0.153 | Potassium channel (ATP-sensitive) blocker | |||
| 0.148 | 0.003 | 0.148 | CC chemokine 4 receptor antagonist | 0.062 0.015 CHEMBL1176 | ||
| 0.162 | 0.02 | 0.182 | Ca2+-transporting ATPase inhibitor | 0.182 0.006 CHEMBL1176 0.179 0.007 CHEMBL3544846 | CHEMBL1176 | |
| 0.149 | 0.01 | 0.149 | Histamine H2 receptor antagonist | |||
| 0.158 | 0.021 | 0.254 | Creatine kinase inhibitor | 0.158 0.021 CHEMBL1176 0.254 0.005 CHEMBL3544846 | CHEMBL3544846 | |
| 0.165 | 0.028 | 0.165 | Antihistaminic | |||
| 0.214 | 0.08 | 0.248 | RNA-directed DNA polymerase inhibitor | 0.239 0.056 CHEMBL1176 0.248 0.051 CHEMBL3544846 | CHEMBL3544846 | |
| 0.142 | 0.009 | 0.142 | Bile acid receptor antagonist | 0.1 0.049 CHEMBL1176 0.113 0.027 CHEMBL3544846 | ||
| 0.133 | 0.003 | 0.133 | Bombesin 1 receptor antagonist | |||
| 0.157 | 0.028 | 0.157 | Histamine antagonist | |||
| 0.147 | 0.02 | 0.147 | Opioid delta receptor antagonist | |||
| 0.128 | 0.003 | 0.128 | Geranylgeranyltransferase inhibitor | |||
| 0.135 | 0.013 | 0.135 | Acetylcholine M4 receptor antagonist | 0.084 0.042 CHEMBL1176 | ||
| 0.135 | 0.014 | 0.135 | Adenosine A3 receptor antagonist | |||
| 0.125 | 0.004 | 0.125 | Cyclin D1 inhibitor | |||
| 0.18 | 0.062 | 0.18 | MAP kinase kinase 5 inhibitor | |||
| 0.142 | 0.025 | 0.142 | Androgen antagonist | |||
| 0.193 | 0.076 | 0.232 | 5 Hydroxytryptamine 3E antagonist | 0.232 0.026 CHEMBL1176 0.187 0.088 CHEMBL3544846 | CHEMBL1176 | |
| 0.153 | 0.037 | 0.153 | Alpha adrenoreceptor antagonist | |||
| 0.291 | 0.175 | 0.503 | 5 Hydroxytryptamine release inhibitor | 0.478 0.04 CHEMBL1176 0.503 0.031 CHEMBL3544846 | CHEMBL3544846 | |
| 0.118 | 0.003 | 0.118 | Heme oxygenase inhibitor | 0.057 0.008 CHEMBL1176 0.049 0.014 CHEMBL3544846 | ||
| 0.123 | 0.009 | 0.123 | Beta 3 adrenoreceptor antagonist | 0.067 0.04 CHEMBL3544846 | ||
| 0.224 | 0.111 | 0.475 | 5 Hydroxytryptamine uptake stimulant | 0.475 0.005 CHEMBL1176 0.469 0.005 CHEMBL3544846 | CHEMBL1176 | |
| 0.154 | 0.041 | 0.154 | Acetylcholine muscarinic antagonist | |||
| 0.114 | 0.004 | 0.114 | Glucocorticoid antagonist | |||
| 0.156 | 0.049 | 0.156 | Cholinergic antagonist | |||
| 0.154 | 0.048 | 0.154 | Acetylcholine antagonist | |||
| 0.141 | 0.039 | 0.141 | Chelator | |||
| 0.099 | 0.009 | 0.104 | Exportin-1 inhibitor | 0.104 0.008 CHEMBL1176 0.074 0.034 CHEMBL3544846 | CHEMBL1176 | |
| 0.091 | 0.003 | 0.091 | CYP24 inhibitor | 0.071 0.004 CHEMBL1176 0.054 0.005 CHEMBL3544846 | ||
| 0.135 | 0.048 | 0.135 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.111 | 0.028 | 0.119 | Histidine decarboxylase inhibitor | 0.067 0.054 CHEMBL1176 0.119 0.026 CHEMBL3544846 | CHEMBL3544846 | |
| 0.115 | 0.033 | 0.115 | Histamine N-methyltransferase inhibitor | 0.102 0.044 CHEMBL1176 0.094 0.052 CHEMBL3544846 | ||
| 0.116 | 0.039 | 0.116 | MAP kinase kinase 1 inhibitor | |||
| 0.122 | 0.048 | 0.191 | GABA C receptor agonist | 0.191 0.022 CHEMBL1176 0.16 0.03 CHEMBL3544846 | CHEMBL1176 | |
| 0.113 | 0.04 | 0.113 | Alcohol dehydrogenase inhibitor | 0.097 0.055 CHEMBL3544846 | ||
| 0.103 | 0.031 | 0.103 | Opioid mu receptor antagonist | |||
| 0.095 | 0.024 | 0.095 | Adenosine A1 receptor antagonist | |||
| 0.087 | 0.018 | 0.097 | Glutamate (mGluR6) antagonist | 0.097 0.012 CHEMBL1176 0.084 0.02 CHEMBL3544846 | CHEMBL1176 | |
| 0.069 | 0.005 | 0.069 | Histamine H1 receptor agonist | 0.067 0.005 CHEMBL1176 0.042 0.034 CHEMBL3544846 | ||
| 0.091 | 0.027 | 0.091 | Adenosine A2a receptor antagonist | |||
| 0.089 | 0.025 | 0.089 | Acetylcholine M2 receptor antagonist | |||
| 0.245 | 0.182 | 0.386 | Antibacterial | 0.329 0.115 CHEMBL1176 0.386 0.083 CHEMBL3544846 | CHEMBL3544846 | |
| 0.089 | 0.027 | 0.089 | Alpha 1d adrenoreceptor antagonist | |||
| 0.091 | 0.029 | 0.091 | Calcium channel L-type blocker | 0.086 0.033 CHEMBL1176 | ||
| 0.154 | 0.095 | 0.192 | ATPase inhibitor | 0.187 0.05 CHEMBL1176 0.192 0.044 CHEMBL3544846 | CHEMBL3544846 | |
| 0.102 | 0.044 | 0.102 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.089 | 0.031 | 0.089 | Adenosine A2 receptor antagonist | |||
| 0.142 | 0.085 | 0.187 | GABA C receptor rho-2 antagonist | 0.187 0.037 CHEMBL1176 0.183 0.04 CHEMBL3544846 | CHEMBL1176 | |
| 0.103 | 0.046 | 0.103 | Opioid antagonist | |||
| 0.102 | 0.046 | 0.102 | Alpha 2d adrenoreceptor antagonist | 0.09 0.071 CHEMBL1176 | ||
| 0.07 | 0.015 | 0.07 | Potassium channel Kv1.3 blocker | |||
| 0.138 | 0.086 | 0.138 | NOS3 expression enhancer | |||
| 0.074 | 0.022 | 0.074 | Beta 1 adrenoreceptor antagonist | |||
| 0.078 | 0.026 | 0.171 | Dopamine uptake inhibitor | 0.171 0.008 CHEMBL1176 0.128 0.013 CHEMBL3544846 | CHEMBL1176 | |
| 0.066 | 0.014 | 0.066 | Bombesin antagonist | |||
| 0.061 | 0.01 | 0.061 | Alpha 1d adrenoreceptor agonist | 0.049 0.017 CHEMBL1176 0.038 0.028 CHEMBL3544846 | ||
| 0.208 | 0.158 | 0.388 | Cholesterol antagonist | 0.324 0.077 CHEMBL1176 0.388 0.052 CHEMBL3544846 | CHEMBL3544846 | |
| 0.082 | 0.032 | 0.082 | Dopamine D4 antagonist | |||
| 0.138 | 0.088 | 0.138 | MAP kinase 3 inhibitor | 0.133 0.099 CHEMBL1176 | ||
| 0.061 | 0.013 | 0.061 | Geranyltranstransferase inhibitor | |||
| 0.102 | 0.055 | 0.176 | Electrolyte absorption antagonist | 0.176 0.012 CHEMBL1176 0.137 0.025 CHEMBL3544846 | CHEMBL1176 | |
| 0.061 | 0.015 | 0.061 | Dopamine beta hydroxylase inhibitor | 0.048 0.035 CHEMBL1176 0.055 0.021 CHEMBL3544846 | ||
| 0.094 | 0.05 | 0.14 | NADH dehydrogenase inhibitor | 0.14 0.02 CHEMBL1176 0.139 0.021 CHEMBL3544846 | CHEMBL1176 | |
| 0.199 | 0.158 | 0.232 | Insulysin inhibitor | 0.213 0.138 CHEMBL1176 0.232 0.115 CHEMBL3544846 | CHEMBL3544846 | |
| 0.15 | 0.113 | 0.305 | Succinate dehydrogenase inhibitor | 0.289 0.013 CHEMBL1176 0.305 0.01 CHEMBL3544846 | CHEMBL3544846 | |
| 0.164 | 0.127 | 0.658 | Aldehyde oxidase inhibitor | 0.48 0.036 CHEMBL1176 0.658 0.012 CHEMBL3544846 | CHEMBL3544846 | |
| 0.066 | 0.034 | 0.082 | Corticotropin releasing factor 2 receptor antagonist | 0.082 0.015 CHEMBL1176 | CHEMBL1176 | |
| 0.083 | 0.051 | 0.083 | Alpha 1 adrenoreceptor antagonist | |||
| 0.05 | 0.021 | 0.05 | Glutamate (mGluR4) antagonist | 0.042 0.034 CHEMBL1176 | ||
| 0.135 | 0.107 | 0.167 | CF transmembrane conductance regulator agonist | 0.141 0.094 CHEMBL1176 0.167 0.051 CHEMBL3544846 | CHEMBL3544846 | |
| 0.062 | 0.034 | 0.062 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.113 | 0.086 | 0.23 | Amylase inhibitor | 0.134 0.073 CHEMBL1176 0.23 0.034 CHEMBL3544846 | CHEMBL3544846 | |
| 0.182 | 0.155 | 0.282 | Neuropeptide Y2 antagonist | 0.282 0.029 CHEMBL1176 0.281 0.029 CHEMBL3544846 | CHEMBL1176 | |
| 0.067 | 0.042 | 0.067 | Beta adrenoreceptor antagonist | |||
| 0.047 | 0.024 | 0.047 | Beta adrenoreceptor agonist | |||
| 0.035 | 0.011 | 0.035 | MAP3K8 inhibitor | |||
| 0.066 | 0.043 | 0.079 | Aryl hydrocarbon receptor antagonist | 0.079 0.028 CHEMBL1176 0.072 0.035 CHEMBL3544846 | CHEMBL1176 | |
| 0.046 | 0.024 | 0.059 | Nerve growth factor antagonist | 0.059 0.01 CHEMBL1176 0.045 0.025 CHEMBL3544846 | CHEMBL1176 | |
| 0.099 | 0.078 | 0.099 | GABA receptor agonist | |||
| 0.065 | 0.044 | 0.076 | Dopamine D1 antagonist | 0.076 0.035 CHEMBL3544846 | CHEMBL3544846 | |
| 0.052 | 0.031 | 0.052 | Alpha 1b adrenoreceptor agonist | |||
| 0.098 | 0.08 | 0.189 | DOPA decarboxylase inhibitor | 0.141 0.026 CHEMBL1176 0.189 0.008 CHEMBL3544846 | CHEMBL3544846 | |
| 0.101 | 0.083 | 0.102 | Calcium channel (voltage-sensitive) blocker | 0.102 0.081 CHEMBL1176 | CHEMBL1176 | |
| 0.039 | 0.022 | 0.053 | Glutamate (mGluR3) antagonist | 0.053 0.011 CHEMBL1176 0.049 0.013 CHEMBL3544846 | CHEMBL1176 | |
| 0.03 | 0.013 | 0.03 | Prostaglandin H2 antagonist | |||
| 0.05 | 0.033 | 0.05 | Bombesin 2 receptor antagonist | |||
| 0.037 | 0.022 | 0.037 | p53 inhibitor | |||
| 0.118 | 0.102 | 0.473 | Peroxidase inhibitor | 0.284 0.04 CHEMBL1176 0.473 0.012 CHEMBL3544846 | CHEMBL3544846 | |
| 0.101 | 0.086 | 0.101 | CDK3/cyclin E inhibitor | |||
| 0.196 | 0.182 | 0.268 | Antithrombotic | 0.251 0.125 CHEMBL1176 0.268 0.112 CHEMBL3544846 | CHEMBL3544846 | |
| 0.028 | 0.015 | 0.044 | Thymidine phosphorylase inhibitor | 0.044 0.005 CHEMBL1176 0.035 0.008 CHEMBL3544846 | CHEMBL1176 | |
| 0.029 | 0.016 | 0.029 | LFA antagonist | 0.026 0.022 CHEMBL1176 | ||
| 0.111 | 0.098 | 0.112 | Calcium channel blocker | 0.112 0.096 CHEMBL1176 | CHEMBL1176 | |
| 0.057 | 0.045 | 0.057 | Acetylcholine M3 receptor antagonist | 0.053 0.05 CHEMBL3544846 | ||
| 0.043 | 0.032 | 0.043 | Glutamate (mGluR group III) antagonist | |||
| 0.02 | 0.01 | 0.047 | Alpha 2c adrenoreceptor agonist | 0.047 0.004 CHEMBL1176 0.026 0.005 CHEMBL3544846 | CHEMBL1176 | |
| 0.05 | 0.04 | 0.05 | Ornithine carbamoyltransferase inhibitor | |||
| 0.072 | 0.063 | 0.12 | GABA B receptor agonist | 0.098 0.018 CHEMBL1176 0.12 0.007 CHEMBL3544846 | CHEMBL3544846 | |
| 0.041 | 0.032 | 0.041 | Histamine H2 receptor agonist | |||
| 0.021 | 0.014 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.024 0.008 CHEMBL1176 0.02 0.018 CHEMBL3544846 | CHEMBL1176 | |
| 0.03 | 0.023 | 0.032 | Potassium channel small-conductance Ca-activated activator | 0.032 0.021 CHEMBL1176 | CHEMBL1176 | |
| 0.069 | 0.064 | 0.085 | Nicotinic alpha4beta2 receptor antagonist | 0.085 0.045 CHEMBL1176 | CHEMBL1176 | |
| 0.013 | 0.008 | 0.013 | Egl nine homolog 3 inhibitor | |||
| 0.022 | 0.018 | 0.022 | ICAM 1 antagonist | |||
| 0.024 | 0.021 | 0.026 | Complement factor 1s inhibitor | 0.026 0.015 CHEMBL1176 | CHEMBL1176 | |
| 0.039 | 0.036 | 0.039 | Angiotensin AT1 receptor antagonist | |||
| 0.049 | 0.046 | 0.103 | Alcohol oxidase inhibitor | 0.055 0.039 CHEMBL1176 0.103 0.017 CHEMBL3544846 | CHEMBL3544846 | |
| 0.164 | 0.161 | 0.485 | 5 Hydroxytryptamine release stimulant | 0.472 0.032 CHEMBL1176 0.485 0.03 CHEMBL3544846 | CHEMBL3544846 | |
| 0.02 | 0.019 | 0.02 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.037 | 0.036 | 0.04 | Thymidine kinase inhibitor | 0.04 0.03 CHEMBL1176 | CHEMBL1176 | |
| 0.025 | 0.025 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.018 CHEMBL1176 | CHEMBL1176 | |
| 0.017 | 0.018 | 0.071 | Alpha 2b adrenoreceptor agonist | 0.071 0.003 CHEMBL1176 0.04 0.004 CHEMBL3544846 | CHEMBL1176 | |
| 0.058 | 0.06 | 0.062 | Beta 2 adrenoreceptor agonist | 0.062 0.041 CHEMBL3544846 | CHEMBL3544846 | |
| 0.087 | 0.092 | 0.089 | AMP-activated protein kinase stimulant | 0.089 0.087 CHEMBL3544846 | CHEMBL3544846 | |
| 0.062 | 0.067 | 0.081 | MDM2 inhibitor | 0.081 0.019 CHEMBL1176 0.069 0.041 CHEMBL3544846 | CHEMBL1176 | |
| 0.024 | 0.032 | 0.03 | Purinergic P2Y15 antagonist | 0.03 0.018 CHEMBL1176 | CHEMBL1176 | |
| 0.065 | 0.074 | 0.081 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.081 0.035 CHEMBL1176 | CHEMBL1176 | |
| 0.166 | 0.175 | 0.181 | DNA synthesis inhibitor | 0.181 0.151 CHEMBL3544846 | CHEMBL3544846 | |
| 0.046 | 0.056 | 0.056 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.056 0.039 CHEMBL1176 | CHEMBL1176 | |
| 0.086 | 0.097 | 0.11 | Adenylate kinase inhibitor | 0.11 0.053 CHEMBL1176 0.096 0.075 CHEMBL3544846 | CHEMBL1176 | |
| 0.017 | 0.028 | 0.021 | Glutamate (mGluR1a) agonist | 0.021 0.017 CHEMBL1176 | CHEMBL1176 | |
| 0.048 | 0.059 | 0.068 | Carbamoyl phosphate synthetase inhibitor | 0.068 0.036 CHEMBL1176 0.056 0.047 CHEMBL3544846 | CHEMBL1176 | |
| 0.018 | 0.031 | 0.036 | Kynurenine 3 monooxygenase inhibitor | 0.036 0.012 CHEMBL1176 0.024 0.021 CHEMBL3544846 | CHEMBL1176 | |
| 0.012 | 0.025 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 CHEMBL1176 | CHEMBL1176 | |
| 0.052 | 0.066 | 0.07 | Acetylcholine M5 receptor agonist | 0.07 0.044 CHEMBL1176 | CHEMBL1176 | |
| 0.02 | 0.035 | 0.039 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 CHEMBL1176 0.039 0.009 CHEMBL3544846 | CHEMBL3544846 | |
| 0.035 | 0.052 | 0.05 | CF transmembrane conductance regulator antagonist | 0.043 0.018 CHEMBL1176 0.05 0.008 CHEMBL3544846 | CHEMBL3544846 | |
| 0.017 | 0.036 | 0.029 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.029 0.018 CHEMBL1176 | CHEMBL1176 | |
| 0.021 | 0.041 | 0.028 | Nicotinic alpha3beta4 receptor agonist | 0.028 0.024 CHEMBL1176 | CHEMBL1176 | |
| 0.023 | 0.046 | 0.041 | Purinergic P2X7 antagonist | 0.041 0.02 CHEMBL1176 | CHEMBL1176 | |
| 0.026 | 0.051 | 0.033 | Glutamate (mGluR4) agonist | 0.033 0.025 CHEMBL1176 | CHEMBL1176 | |
| 0.08 | 0.105 | 0.369 | Cystathionine beta-synthase inhibitor | 0.239 0.017 CHEMBL1176 0.369 0.006 CHEMBL3544846 | CHEMBL3544846 | |
| 0.089 | 0.117 | 0.107 | Acetylcholine release stimulant | 0.107 0.072 CHEMBL1176 | CHEMBL1176 | |
| 0.052 | 0.081 | 0.097 | Porphobilinogen synthase inhibitor | 0.075 0.051 CHEMBL1176 0.097 0.037 CHEMBL3544846 | CHEMBL3544846 | |
| 0.022 | 0.052 | 0.038 | Phosphoglycerate kinase inhibitor | 0.037 0.022 CHEMBL1176 0.038 0.021 CHEMBL3544846 | CHEMBL3544846 | |
| 0.077 | 0.107 | 0.118 | GABA C receptor rho-1 antagonist | 0.118 0.042 CHEMBL1176 0.106 0.055 CHEMBL3544846 | CHEMBL1176 | |
| 0.03 | 0.062 | 0.042 | Glutamate (mGluR group III) agonist | 0.042 0.031 CHEMBL1176 | CHEMBL1176 | |
| 0.073 | 0.105 | 0.152 | UDP-glucose 4-epimerase inhibitor | 0.147 0.03 CHEMBL1176 0.152 0.028 CHEMBL3544846 | CHEMBL3544846 | |
| 0.009 | 0.041 | 0.022 | Cyclin T1 inhibitor | 0.022 0.009 CHEMBL1176 | CHEMBL1176 | |
| 0.047 | 0.08 | 0.061 | 5 Hydroxytryptamine 3 agonist | 0.061 0.047 CHEMBL1176 | CHEMBL1176 | |
| 0.035 | 0.068 | 0.05 | Aldosterone antagonist | 0.05 0.029 CHEMBL1176 | CHEMBL1176 | |
| 0.018 | 0.053 | 0.03 | Integrin alpha2beta1 antagonist | 0.03 0.013 CHEMBL1176 | CHEMBL1176 | |
| 0.018 | 0.054 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.027 0.014 CHEMBL1176 0.033 0.009 CHEMBL3544846 | CHEMBL3544846 | |
| 0.14 | 0.177 | 0.24 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.186 0.086 CHEMBL1176 0.24 0.047 CHEMBL3544846 | CHEMBL3544846 | |
| 0.034 | 0.072 | 0.063 | Purinergic P2X4 antagonist | 0.057 0.017 CHEMBL1176 0.063 0.013 CHEMBL3544846 | CHEMBL3544846 | |
| 0.031 | 0.072 | 0.074 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.065 0.005 CHEMBL1176 0.074 0.004 CHEMBL3544846 | CHEMBL3544846 | |
| 0.069 | 0.11 | 0.141 | D-Ala-D-Ala ligase inhibitor | 0.109 0.02 CHEMBL1176 0.141 0.007 CHEMBL3544846 | CHEMBL3544846 | |
| 0.003 | 0.045 | 0.009 | DNA topoisomerase III inhibitor | 0.009 0.004 CHEMBL1176 | CHEMBL1176 | |
| 0.045 | 0.088 | 0.077 | Pregnane X receptor antagonist | 0.077 0.008 CHEMBL1176 0.073 0.011 CHEMBL3544846 | CHEMBL1176 | |
| 0.011 | 0.054 | 0.026 | Imidazoline I1 receptor antagonist | 0.026 0.009 CHEMBL1176 | CHEMBL1176 | |
| 0.031 | 0.075 | 0.045 | GABA B receptor antagonist | 0.045 0.027 CHEMBL1176 0.04 0.036 CHEMBL3544846 | CHEMBL1176 | |
| 0.035 | 0.079 | 0.045 | Benzodiazepine antagonist | 0.045 0.039 CHEMBL1176 | CHEMBL1176 | |
| 0.077 | 0.123 | 0.151 | GABA C receptor antagonist | 0.151 0.029 CHEMBL1176 0.144 0.034 CHEMBL3544846 | CHEMBL1176 | |
| 0.026 | 0.072 | 0.034 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.029 CHEMBL1176 | CHEMBL1176 | |
| 0.038 | 0.088 | 0.117 | Nicotinic alpha3beta2 receptor antagonist | 0.117 0.005 CHEMBL1176 0.079 0.013 CHEMBL3544846 | CHEMBL1176 | |
| 0.006 | 0.058 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.006 CHEMBL1176 0.012 0.011 CHEMBL3544846 | CHEMBL1176 | |
| 0.026 | 0.08 | 0.048 | Potassium channel Kv1.1 blocker | 0.048 0.015 CHEMBL1176 | CHEMBL1176 | |
| 0.035 | 0.09 | 0.069 | Biliverdin reductase inhibitor | 0.069 0.032 CHEMBL1176 | CHEMBL1176 | |
| 0.065 | 0.12 | 0.236 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.236 0.011 CHEMBL1176 0.196 0.016 CHEMBL3544846 | CHEMBL1176 | |
| 0.049 | 0.107 | 0.091 | Phospholipase D inhibitor | 0.091 0.021 CHEMBL1176 0.072 0.05 CHEMBL3544846 | CHEMBL1176 | |
| 0.023 | 0.081 | 0.04 | Integrin alpha2 antagonist | 0.04 0.02 CHEMBL1176 | CHEMBL1176 | |
| 0.026 | 0.089 | 0.058 | Nicotinic receptor alpha3 subunit antagonist | 0.058 0.02 CHEMBL1176 0.042 0.033 CHEMBL3544846 | CHEMBL1176 | |
| 0.075 | 0.137 | 0.119 | Glutamate (mGluR7) agonist | 0.119 0.031 CHEMBL1176 | CHEMBL1176 | |
| 0.032 | 0.096 | 0.079 | Aconitate hydratase inhibitor | 0.079 0.014 CHEMBL1176 0.061 0.025 CHEMBL3544846 | CHEMBL1176 | |
| 0.048 | 0.114 | 0.084 | Glutamate dehydrogenase inhibitor | 0.084 0.041 CHEMBL1176 0.077 0.047 CHEMBL3544846 | CHEMBL1176 | |
| 0.015 | 0.081 | 0.034 | Fumarate hydratase inhibitor | 0.034 0.024 CHEMBL1176 | CHEMBL1176 | |
| 0.039 | 0.105 | 0.08 | Purinergic P2X1 antagonist | 0.067 0.035 CHEMBL1176 0.08 0.025 CHEMBL3544846 | CHEMBL3544846 | |
| 0.095 | 0.161 | 0.182 | Mannose-6-phosphate isomerase inhibitor | 0.182 0.041 CHEMBL1176 0.177 0.044 CHEMBL3544846 | CHEMBL1176 | |
| 0.035 | 0.101 | 0.075 | Phosphofructokinase-1 inhibitor | 0.075 0.044 CHEMBL1176 0.074 0.045 CHEMBL3544846 | CHEMBL1176 | |
| 0.078 | 0.148 | 0.174 | Cyclooxygenase 3 inhibitor | 0.156 0.044 CHEMBL1176 0.174 0.031 CHEMBL3544846 | CHEMBL3544846 | |
| 0.065 | 0.135 | 0.139 | Carbonic anhydrase III inhibitor | 0.086 0.08 CHEMBL1176 0.139 0.033 CHEMBL3544846 | CHEMBL3544846 | |
| 0.027 | 0.098 | 0.056 | Acyl-CoA dehydrogenase inhibitor | 0.056 0.037 CHEMBL1176 | CHEMBL1176 | |
| 0.119 | 0.19 | 0.288 | Phospholipase C inhibitor | 0.216 0.035 CHEMBL1176 0.288 0.019 CHEMBL3544846 | CHEMBL3544846 | |
| 0.003 | 0.074 | 0.009 | Progesterone receptor A antagonist | 0.009 0.007 CHEMBL1176 | CHEMBL1176 | |
| 0.159 | 0.23 | 0.365 | Tyrosine 3 hydroxylase inhibitor | 0.295 0.036 CHEMBL1176 0.365 0.013 CHEMBL3544846 | CHEMBL3544846 | |
| 0.051 | 0.123 | 0.077 | Calcium channel P-type blocker | 0.077 0.018 CHEMBL1176 0.066 0.038 CHEMBL3544846 | CHEMBL1176 | |
| 0.082 | 0.155 | 0.135 | Interleukin 8 antagonist | 0.121 0.059 CHEMBL1176 0.135 0.045 CHEMBL3544846 | CHEMBL3544846 | |
| 0.019 | 0.092 | 0.03 | Hedgehog signaling activator | 0.03 0.012 CHEMBL1176 0.029 0.016 CHEMBL3544846 | CHEMBL1176 | |
| 0.076 | 0.149 | 0.25 | Alpha-N-acetylglucosaminidase inhibitor | 0.25 0.023 CHEMBL1176 0.195 0.036 CHEMBL3544846 | CHEMBL1176 | |
| 0.103 | 0.178 | 0.155 | Aryl hydrocarbon receptor agonist | 0.149 0.137 CHEMBL1176 0.155 0.131 CHEMBL3544846 | CHEMBL3544846 | |
| 0.031 | 0.107 | 0.057 | Potassium channel (ATP-sensitive) activator | 0.057 0.019 CHEMBL1176 | CHEMBL1176 | |
| 0.032 | 0.109 | 0.06 | Potassium channel (Inward rectifier) activator | 0.06 0.02 CHEMBL1176 | CHEMBL1176 | |
| 0.055 | 0.137 | 0.213 | HIV-1 integrase (Overall Integration) inhibitor | 0.196 0.012 CHEMBL1176 0.213 0.009 CHEMBL3544846 | CHEMBL3544846 | |
| 0.046 | 0.127 | 0.322 | HIV-1 integrase inhibitor | 0.322 0.004 CHEMBL1176 0.302 0.004 CHEMBL3544846 | CHEMBL1176 | |
| 0.06 | 0.144 | 0.219 | Ferrochelatase inhibitor | 0.219 0.018 CHEMBL1176 0.112 0.06 CHEMBL3544846 | CHEMBL1176 | |
| 0.019 | 0.104 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.021 CHEMBL1176 0.036 0.023 CHEMBL3544846 | CHEMBL1176 | |
| 0.068 | 0.153 | 0.129 | Glutamate release inhibitor | 0.129 0.017 CHEMBL1176 0.117 0.024 CHEMBL3544846 | CHEMBL1176 | |
| 0.015 | 0.102 | 0.051 | NMDA receptor subunit 3A antagonist | 0.051 0.019 CHEMBL3544846 | CHEMBL3544846 | |
| 0.035 | 0.121 | 0.123 | Phenylalanine 4-hydroxylase inhibitor | 0.076 0.041 CHEMBL1176 0.123 0.017 CHEMBL3544846 | CHEMBL3544846 | |
| 0.031 | 0.118 | 0.049 | Squalene epoxidase inhibitor | 0.047 0.04 CHEMBL1176 0.049 0.036 CHEMBL3544846 | CHEMBL3544846 | |
| 0.061 | 0.15 | 0.178 | 5 Hydroxytryptamine 3A agonist | 0.178 0.022 CHEMBL1176 0.158 0.031 CHEMBL3544846 | CHEMBL1176 | |
| 0.164 | 0.256 | 0.325 | Histamine release inhibitor | 0.239 0.164 CHEMBL1176 0.325 0.111 CHEMBL3544846 | CHEMBL3544846 | |
| 0.008 | 0.101 | 0.024 | Uridine phosphorylase inhibitor | 0.024 0.023 CHEMBL1176 | CHEMBL1176 | |
| 0.096 | 0.189 | 0.226 | Anesthetic general | 0.2 0.074 CHEMBL1176 0.226 0.061 CHEMBL3544846 | CHEMBL3544846 | |
| 0.018 | 0.112 | 0.04 | Guanylate cyclase inhibitor | 0.04 0.033 CHEMBL1176 | CHEMBL1176 | |
| 0.042 | 0.137 | 0.075 | Glutamate (mGluR7) antagonist | 0.075 0.035 CHEMBL1176 0.07 0.042 CHEMBL3544846 | CHEMBL1176 | |
| 0.087 | 0.183 | 0.215 | Psychostimulant | 0.215 0.072 CHEMBL1176 0.202 0.079 CHEMBL3544846 | CHEMBL1176 | |
| 0.025 | 0.121 | 0.039 | Vanilloid 3 antagonist | 0.039 0.025 CHEMBL1176 0.036 0.033 CHEMBL3544846 | CHEMBL1176 | |
| 0.006 | 0.104 | 0.018 | Thromboxane A2 agonist | 0.018 0.008 CHEMBL1176 | CHEMBL1176 | |
| 0.088 | 0.187 | 0.207 | Arachidonic acid antagonist | 0.199 0.034 CHEMBL1176 0.207 0.027 CHEMBL3544846 | CHEMBL3544846 | |
| 0.024 | 0.124 | 0.052 | Argininosuccinate synthase inhibitor | 0.052 0.045 CHEMBL1176 | CHEMBL1176 | |
| 0.014 | 0.114 | 0.06 | ATP citrate lysase inhibitor | 0.041 0.012 CHEMBL1176 0.06 0.005 CHEMBL3544846 | CHEMBL3544846 | |
| 0.022 | 0.126 | 0.042 | Glutamate (mGluR8) agonist | 0.042 0.019 CHEMBL1176 0.038 0.026 CHEMBL3544846 | CHEMBL1176 | |
| 0.056 | 0.163 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.033 CHEMBL3544846 | CHEMBL3544846 | |
| 0.07 | 0.177 | 0.204 | Aldehyde dehydrogenase inhibitor | 0.14 0.054 CHEMBL1176 0.204 0.027 CHEMBL3544846 | CHEMBL3544846 | |
| 0.088 | 0.197 | 0.143 | Thiol protease inhibitor | 0.143 0.076 CHEMBL1176 0.121 0.116 CHEMBL3544846 | CHEMBL1176 | |
| 0.01 | 0.119 | 0.034 | Liver X receptor beta antagonist | 0.025 0.024 CHEMBL1176 0.034 0.016 CHEMBL3544846 | CHEMBL3544846 | |
| 0.108 | 0.218 | 0.258 | Neurotrophic factor enhancer | 0.205 0.072 CHEMBL1176 0.258 0.034 CHEMBL3544846 | CHEMBL3544846 | |
| 0.081 | 0.193 | 0.173 | Diuretic | 0.173 0.058 CHEMBL1176 0.153 0.075 CHEMBL3544846 | CHEMBL1176 | |
| 0.042 | 0.155 | 0.079 | Potassium channel (Tandem pore domain) blocker | 0.079 0.037 CHEMBL1176 | CHEMBL1176 | |
| 0.016 | 0.13 | 0.11 | Dopamine D5 agonist | 0.064 0.01 CHEMBL1176 0.11 0.004 CHEMBL3544846 | CHEMBL3544846 | |
| 0.035 | 0.15 | 0.054 | Heat shock protein 90 beta antagonist | 0.054 0.051 CHEMBL3544846 | CHEMBL3544846 | |
| 0.08 | 0.196 | 0.142 | Sphingosine 1-phosphate receptor 4 antagonist | 0.142 0.041 CHEMBL1176 0.127 0.06 CHEMBL3544846 | CHEMBL1176 | |
| 0.008 | 0.124 | 0.027 | CXC chemokine 2 receptor antagonist | 0.027 0.017 CHEMBL3544846 | CHEMBL3544846 | |
| 0.026 | 0.143 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.023 CHEMBL1176 0.051 0.028 CHEMBL3544846 | CHEMBL1176 | |
| 0.14 | 0.259 | 0.257 | Vasodilator, peripheral | 0.253 0.125 CHEMBL1176 0.257 0.122 CHEMBL3544846 | CHEMBL3544846 | |
| 0.03 | 0.15 | 0.068 | Botulinum neurotoxin type A inhibitor | 0.066 0.03 CHEMBL1176 0.068 0.027 CHEMBL3544846 | CHEMBL3544846 | |
| 0.07 | 0.191 | 0.145 | Cathepsin H inhibitor | 0.145 0.05 CHEMBL1176 0.115 0.082 CHEMBL3544846 | CHEMBL1176 | |
| 0.054 | 0.176 | 0.132 | Anabolic | 0.117 0.043 CHEMBL1176 0.132 0.03 CHEMBL3544846 | CHEMBL3544846 | |
| 0.022 | 0.144 | 0.095 | NMDA receptor glycine site agonist | 0.095 0.019 CHEMBL1176 0.077 0.031 CHEMBL3544846 | CHEMBL1176 | |
| 0.036 | 0.158 | 0.14 | Calcium antagonist | 0.14 0.026 CHEMBL1176 0.073 0.07 CHEMBL3544846 | CHEMBL1176 | |
| 0.114 | 0.237 | 0.162 | Heat shock protein 70 antagonist | 0.15 0.045 CHEMBL1176 0.162 0.025 CHEMBL3544846 | CHEMBL3544846 | |
| 0.06 | 0.185 | 0.134 | Estrogen-related receptor beta agonist | 0.102 0.023 CHEMBL1176 0.134 0.006 CHEMBL3544846 | CHEMBL3544846 | |
| 0.032 | 0.159 | 0.082 | NMDA receptor agonist | 0.082 0.027 CHEMBL1176 0.069 0.037 CHEMBL3544846 | CHEMBL1176 | |
| 0.051 | 0.18 | 0.128 | Triose-phosphate isomerase inhibitor | 0.128 0.028 CHEMBL1176 0.116 0.034 CHEMBL3544846 | CHEMBL1176 | |
| 0.061 | 0.191 | 0.091 | CC chemokine 5 receptor agonist | 0.082 0.056 CHEMBL1176 0.091 0.035 CHEMBL3544846 | CHEMBL3544846 | |
| 0.048 | 0.18 | 0.105 | Vanilloid 4 agonist | 0.105 0.013 CHEMBL1176 0.083 0.036 CHEMBL3544846 | CHEMBL1176 | |
| 0.018 | 0.151 | 0.067 | NMDA receptor subunit 3B antagonist | 0.067 0.017 CHEMBL3544846 | CHEMBL3544846 | |
| 0.036 | 0.175 | 0.157 | Potassium channel (Ca-activated) activator | 0.104 0.052 CHEMBL1176 0.157 0.026 CHEMBL3544846 | CHEMBL3544846 | |
| 0.025 | 0.164 | 0.197 | Cannabinoid CB1 receptor antagonist | 0.197 0.005 CHEMBL1176 0.116 0.012 CHEMBL3544846 | CHEMBL1176 | |
| 0.034 | 0.174 | 0.061 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.061 0.04 CHEMBL3544846 | CHEMBL3544846 | |
| 0.037 | 0.177 | 0.12 | GABA aminotransferase inhibitor | 0.098 0.029 CHEMBL1176 0.12 0.016 CHEMBL3544846 | CHEMBL3544846 | |
| 0.056 | 0.196 | 0.132 | Beta amyloid protein antagonist | 0.132 0.055 CHEMBL1176 0.105 0.083 CHEMBL3544846 | CHEMBL1176 | |
| 0.026 | 0.167 | 0.094 | Sphingosine 1-phosphate receptor 4 agonist | 0.094 0.028 CHEMBL1176 0.084 0.034 CHEMBL3544846 | CHEMBL1176 | |
| 0.024 | 0.166 | 0.112 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.064 0.026 CHEMBL1176 0.112 0.008 CHEMBL3544846 | CHEMBL3544846 | |
| 0.095 | 0.239 | 0.227 | 3C-like protease (Human coronavirus) inhibitor | 0.227 0.038 CHEMBL1176 0.175 0.069 CHEMBL3544846 | CHEMBL1176 | |
| 0.032 | 0.177 | 0.083 | Aminopeptidase I inhibitor | 0.083 0.039 CHEMBL1176 0.078 0.044 CHEMBL3544846 | CHEMBL1176 | |
| 0.054 | 0.2 | 0.347 | Beta glucuronidase inhibitor | 0.211 0.011 CHEMBL1176 0.347 0.005 CHEMBL3544846 | CHEMBL3544846 | |
| 0.09 | 0.237 | 0.2 | Interferon gamma antagonist | 0.165 0.061 CHEMBL1176 0.2 0.041 CHEMBL3544846 | CHEMBL3544846 | |
| 0.019 | 0.167 | 0.051 | 5 Hydroxytryptamine 2B agonist | 0.051 0.013 CHEMBL1176 | CHEMBL1176 | |
| 0.022 | 0.171 | 0.046 | Kainate receptor agonist | 0.046 0.019 CHEMBL1176 0.042 0.026 CHEMBL3544846 | CHEMBL1176 | |
| 0.01 | 0.16 | 0.042 | Nicotinic acid receptor agonist | 0.042 0.019 CHEMBL3544846 | CHEMBL3544846 | |
| 0.03 | 0.18 | 0.078 | Dihydroorotate oxidase inhibitor | 0.075 0.013 CHEMBL1176 0.078 0.012 CHEMBL3544846 | CHEMBL3544846 | |
| 0.005 | 0.155 | 0.023 | Nicotinic acid receptor 1 antagonist | 0.023 0.007 CHEMBL3544846 | CHEMBL3544846 | |
| 0.079 | 0.231 | 0.131 | Heat shock protein 90 alpha antagonist | 0.131 0.11 CHEMBL3544846 | CHEMBL3544846 | |
| 0.016 | 0.169 | 0.036 | Glutamate (mGluR3) agonist | 0.031 0.024 CHEMBL1176 0.036 0.015 CHEMBL3544846 | CHEMBL3544846 | |
| 0.038 | 0.193 | 0.146 | M18 aspartyl aminopeptidase inhibitor | 0.146 0.054 CHEMBL3544846 | CHEMBL3544846 | |
| 0.02 | 0.177 | 0.059 | Adenylate cyclase 1 inhibitor | 0.059 0.018 CHEMBL1176 0.052 0.025 CHEMBL3544846 | CHEMBL1176 | |
| 0.084 | 0.241 | 0.163 | Adenylate cyclase stimulant | 0.146 0.07 CHEMBL1176 0.163 0.044 CHEMBL3544846 | CHEMBL3544846 | |
| 0.016 | 0.178 | 0.073 | NMDA 2 receptor antagonist | 0.073 0.049 CHEMBL3544846 | CHEMBL3544846 | |
| 0.037 | 0.201 | 0.115 | Aminopeptidase B inhibitor | 0.115 0.056 CHEMBL1176 0.113 0.057 CHEMBL3544846 | CHEMBL1176 | |
| 0.081 | 0.246 | 0.173 | Interleukin agonist | 0.173 0.145 CHEMBL1176 | CHEMBL1176 | |
| 0.027 | 0.192 | 0.1 | Glutamate decarboxylase inhibitor | 0.071 0.054 CHEMBL1176 0.1 0.03 CHEMBL3544846 | CHEMBL3544846 | |
| 0.008 | 0.178 | 0.03 | Free fatty acid receptor 1 antagonist | 0.03 0.029 CHEMBL1176 | CHEMBL1176 | |
| 0.008 | 0.18 | 0.021 | Prostaglandin F2 alpha agonist | 0.021 0.018 CHEMBL3544846 | CHEMBL3544846 | |
| 0.043 | 0.216 | 0.16 | Cholesterol synthesis inhibitor | 0.128 0.058 CHEMBL1176 0.16 0.04 CHEMBL3544846 | CHEMBL3544846 | |
| 0.162 | 0.335 | 0.371 | Apoptosis agonist | 0.371 0.128 CHEMBL3544846 | CHEMBL3544846 | |
| 0.013 | 0.187 | 0.045 | GABA uptake inhibitor | 0.045 0.02 CHEMBL1176 0.038 0.029 CHEMBL3544846 | CHEMBL1176 | |
| 0.048 | 0.222 | 0.087 | Bromodomain-containing protein 2 inhibitor | 0.087 0.061 CHEMBL1176 | CHEMBL1176 | |
| 0.069 | 0.249 | 0.147 | Transcription factor STAT6 inhibitor | 0.139 0.033 CHEMBL1176 0.147 0.025 CHEMBL3544846 | CHEMBL3544846 | |
| 0.035 | 0.215 | 0.056 | Leukotriene C antagonist | 0.053 0.051 CHEMBL1176 0.056 0.04 CHEMBL3544846 | CHEMBL3544846 | |
| 0.039 | 0.219 | 0.109 | Sphingomyelinase inhibitor | 0.109 0.05 CHEMBL1176 0.093 0.068 CHEMBL3544846 | CHEMBL1176 | |
| 0.087 | 0.27 | 0.151 | Sphingosine 1-phosphate receptor 5 antagonist | 0.151 0.06 CHEMBL1176 0.146 0.068 CHEMBL3544846 | CHEMBL1176 | |
| 0.079 | 0.264 | 0.192 | Melanin inhibitor | 0.142 0.093 CHEMBL1176 0.192 0.044 CHEMBL3544846 | CHEMBL3544846 | |
| 0.058 | 0.244 | 0.195 | Nav1.2 sodium channel blocker | 0.195 0.036 CHEMBL1176 0.154 0.055 CHEMBL3544846 | CHEMBL1176 | |
| 0.016 | 0.202 | 0.042 | Dihydroorotase inhibitor | 0.042 0.035 CHEMBL1176 | CHEMBL1176 | |
| 0.057 | 0.243 | 0.131 | NADPH oxidase inhibitor | 0.131 0.07 CHEMBL3544846 | CHEMBL3544846 | |
| 0.049 | 0.235 | 0.122 | Alkaline phosphatase inhibitor | 0.122 0.084 CHEMBL3544846 | CHEMBL3544846 | |
| 0.01 | 0.197 | 0.031 | Thyroid hormone agonist | 0.031 0.012 CHEMBL3544846 | CHEMBL3544846 | |
| 0.013 | 0.2 | 0.034 | Estrogen-related receptor gamma antagonist | 0.034 0.01 CHEMBL3544846 | CHEMBL3544846 | |
| 0.039 | 0.228 | 0.09 | Caspase 7 inhibitor | 0.09 0.041 CHEMBL1176 0.075 0.073 CHEMBL3544846 | CHEMBL1176 | |
| 0.049 | 0.238 | 0.089 | Granulocyte macrophage colony stimulating factor agonist | 0.089 0.054 CHEMBL1176 0.087 0.058 CHEMBL3544846 | CHEMBL1176 | |
| 0.015 | 0.206 | 0.041 | Liver X receptor alpha agonist | 0.041 0.029 CHEMBL3544846 | CHEMBL3544846 | |
| 0.013 | 0.212 | 0.036 | Delayed rectifier potassium channel blocker | 0.036 0.029 CHEMBL1176 | CHEMBL1176 | |
| 0.022 | 0.222 | 0.058 | Sphingosine kinase 2 inhibitor | 0.053 0.042 CHEMBL1176 0.058 0.034 CHEMBL3544846 | CHEMBL3544846 | |
| 0.021 | 0.223 | 0.213 | Cannabinoid receptor antagonist | 0.213 0.007 CHEMBL1176 0.128 0.019 CHEMBL3544846 | CHEMBL1176 | |
| 0.019 | 0.222 | 0.066 | Amidase inhibitor | 0.066 0.056 CHEMBL1176 0.063 0.06 CHEMBL3544846 | CHEMBL1176 | |
| 0.04 | 0.245 | 0.089 | Glutathione S-transferase inhibitor | 0.086 0.053 CHEMBL1176 0.089 0.048 CHEMBL3544846 | CHEMBL3544846 | |
| 0.023 | 0.23 | 0.043 | Alpha 1L adrenoreceptor agonist | 0.043 0.029 CHEMBL1176 | CHEMBL1176 | |
| 0.018 | 0.225 | 0.081 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.081 0.024 CHEMBL3544846 | CHEMBL3544846 | |
| 0.114 | 0.325 | 0.28 | Vasodilator, coronary | 0.274 0.111 CHEMBL1176 0.28 0.105 CHEMBL3544846 | CHEMBL3544846 | |
| 0.035 | 0.246 | 0.057 | Immunoglobulin Fc receptor antagonist | 0.057 0.031 CHEMBL1176 0.053 0.047 CHEMBL3544846 | CHEMBL1176 | |
| 0.05 | 0.263 | 0.14 | Carbonic anhydrase XV inhibitor | 0.107 0.058 CHEMBL1176 0.14 0.035 CHEMBL3544846 | CHEMBL3544846 | |
| 0.025 | 0.238 | 0.141 | NMDA receptor antagonist | 0.083 0.061 CHEMBL1176 0.141 0.027 CHEMBL3544846 | CHEMBL3544846 | |
| 0.035 | 0.249 | 0.091 | Glycine receptor agonist | 0.091 0.027 CHEMBL1176 0.089 0.029 CHEMBL3544846 | CHEMBL1176 | |
| 0.029 | 0.246 | 0.106 | Glycine receptor antagonist | 0.106 0.027 CHEMBL1176 0.085 0.049 CHEMBL3544846 | CHEMBL1176 | |
| 0.031 | 0.247 | 0.085 | Myeloperoxidase inhibitor | 0.085 0.058 CHEMBL3544846 | CHEMBL3544846 | |
| 0.006 | 0.224 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.012 CHEMBL3544846 | CHEMBL3544846 | |
| 0.004 | 0.224 | 0.033 | Progesterone antagonist | 0.033 0.026 CHEMBL1176 | CHEMBL1176 | |
| 0.005 | 0.229 | 0.042 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.042 0.015 CHEMBL3544846 | CHEMBL3544846 | |
| 0.041 | 0.265 | 0.087 | Xanthine oxidase inhibitor | 0.087 0.077 CHEMBL3544846 | CHEMBL3544846 | |
| 0.068 | 0.294 | 0.168 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.168 0.123 CHEMBL3544846 | CHEMBL3544846 | |
| 0.01 | 0.237 | 0.043 | Oxytocin agonist | 0.043 0.029 CHEMBL3544846 | CHEMBL3544846 | |
| 0.018 | 0.245 | 0.078 | Catalase inhibitor | 0.078 0.049 CHEMBL1176 0.07 0.055 CHEMBL3544846 | CHEMBL1176 | |
| 0.018 | 0.248 | 0.064 | Androgen agonist | 0.053 0.051 CHEMBL1176 0.064 0.036 CHEMBL3544846 | CHEMBL3544846 | |
| 0.023 | 0.255 | 0.225 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.15 0.019 CHEMBL1176 0.225 0.007 CHEMBL3544846 | CHEMBL3544846 | |
| 0.01 | 0.243 | 0.07 | NMDA 2C receptor antagonist | 0.056 0.05 CHEMBL1176 0.07 0.033 CHEMBL3544846 | CHEMBL3544846 | |
| 0.005 | 0.245 | 0.035 | Farnesoid X receptor agonist | 0.035 0.029 CHEMBL1176 | CHEMBL1176 | |
| 0.031 | 0.271 | 0.221 | Urease inhibitor | 0.184 0.012 CHEMBL1176 0.221 0.008 CHEMBL3544846 | CHEMBL3544846 | |
| 0.065 | 0.311 | 0.138 | Sphingosine 1-phosphate receptor 2 antagonist | 0.138 0.058 CHEMBL1176 0.135 0.065 CHEMBL3544846 | CHEMBL1176 | |
| 0.094 | 0.344 | 0.296 | Gastrin inhibitor | 0.296 0.036 CHEMBL1176 0.25 0.079 CHEMBL3544846 | CHEMBL1176 | |
| 0.006 | 0.258 | 0.03 | Protease (Human cytomegalovirus) inhibitor | 0.03 0.008 CHEMBL1176 | CHEMBL1176 | |
| 0.015 | 0.268 | 0.057 | 5 Hydroxytryptamine 2A agonist | 0.057 0.05 CHEMBL1176 | CHEMBL1176 | |
| 0.035 | 0.289 | 0.103 | Interleukin 1 beta converting enzyme inhibitor | 0.1 0.057 CHEMBL1176 0.103 0.053 CHEMBL3544846 | CHEMBL3544846 | |
| 0.025 | 0.281 | 0.047 | CD45 antagonist | 0.047 0.043 CHEMBL3544846 | CHEMBL3544846 | |
| 0.085 | 0.343 | 0.439 | 12-Lipoxygenase inhibitor | 0.308 0.075 CHEMBL1176 0.439 0.031 CHEMBL3544846 | CHEMBL3544846 | |
| 0.077 | 0.335 | 0.258 | 5 Hydroxytryptamine 1E antagonist | 0.258 0.067 CHEMBL1176 0.249 0.076 CHEMBL3544846 | CHEMBL1176 | |
| 0.026 | 0.289 | 0.104 | Macrophage migration inhibitory factor inhibitor | 0.104 0.032 CHEMBL3544846 | CHEMBL3544846 | |
| 0.058 | 0.322 | 0.151 | Hexokinase inhibitor | 0.127 0.108 CHEMBL1176 0.151 0.078 CHEMBL3544846 | CHEMBL3544846 | |
| 0.012 | 0.281 | 0.181 | Prostaglandin-E synthase inhibitor | 0.181 0.008 CHEMBL1176 0.167 0.009 CHEMBL3544846 | CHEMBL1176 | |
| 0.044 | 0.313 | 0.16 | Pyruvate kinase inhibitor | 0.16 0.107 CHEMBL3544846 | CHEMBL3544846 | |
| 0.088 | 0.36 | 0.173 | Neurotensin receptor agonist | 0.149 0.104 CHEMBL1176 0.173 0.059 CHEMBL3544846 | CHEMBL3544846 | |
| 0.008 | 0.285 | 0.057 | NMDA 2A receptor antagonist | 0.057 0.031 CHEMBL3544846 | CHEMBL3544846 | |
| 0.02 | 0.303 | 0.068 | Carbonic anhydrase XIII inhibitor | 0.068 0.06 CHEMBL3544846 | CHEMBL3544846 | |
| 0.049 | 0.337 | 0.12 | Heat shock protein 90 antagonist | 0.12 0.113 CHEMBL3544846 | CHEMBL3544846 | |
| 0.047 | 0.336 | 0.145 | TRPA1 agonist | 0.127 0.051 CHEMBL1176 0.145 0.035 CHEMBL3544846 | CHEMBL3544846 | |
| 0.004 | 0.298 | 0.02 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.02 0.017 CHEMBL3544846 | CHEMBL3544846 | |
| 0.029 | 0.323 | 0.111 | Prolactin inhibitor | 0.083 0.076 CHEMBL1176 0.111 0.045 CHEMBL3544846 | CHEMBL3544846 | |
| 0.027 | 0.34 | 0.091 | Carbonic anhydrase VI inhibitor | 0.091 0.046 CHEMBL3544846 | CHEMBL3544846 | |
| 0.007 | 0.319 | 0.137 | Cannabinoid CB2 receptor antagonist | 0.137 0.009 CHEMBL1176 0.11 0.013 CHEMBL3544846 | CHEMBL1176 | |
| 0.031 | 0.364 | 0.126 | Estrogen receptor alpha antagonist | 0.076 0.056 CHEMBL1176 0.126 0.017 CHEMBL3544846 | CHEMBL3544846 | |
| 0.027 | 0.361 | 0.079 | Keratolytic | 0.079 0.05 CHEMBL3544846 | CHEMBL3544846 | |
| 0.005 | 0.339 | 0.058 | Cannabinoid CB2 receptor agonist | 0.058 0.035 CHEMBL1176 | CHEMBL1176 | |
| 0.006 | 0.346 | 0.126 | Cannabinoid CB1 receptor agonist | 0.126 0.013 CHEMBL1176 0.067 0.037 CHEMBL3544846 | CHEMBL1176 | |
| 0.008 | 0.351 | 0.034 | Histone deacetylase 7 inhibitor | 0.034 0.028 CHEMBL1176 | CHEMBL1176 | |
| 0.011 | 0.359 | 0.065 | Purinergic P2 antagonist | 0.065 0.043 CHEMBL1176 | CHEMBL1176 | |
| 0.044 | 0.396 | 0.125 | Neuropeptide Y1 antagonist | 0.125 0.111 CHEMBL3544846 | CHEMBL3544846 | |
| 0.122 | 0.483 | 0.377 | Caspase 9 stimulant | 0.314 0.179 CHEMBL1176 0.377 0.126 CHEMBL3544846 | CHEMBL3544846 | |
| 0.034 | 0.4 | 0.134 | Toll-Like receptor 2 antagonist | 0.134 0.064 CHEMBL3544846 | CHEMBL3544846 | |
| 0.004 | 0.37 | 0.047 | Estradiol 17 beta-dehydrogenase inhibitor | 0.047 0.026 CHEMBL3544846 | CHEMBL3544846 | |
| 0.006 | 0.383 | 0.099 | Cannabinoid receptor agonist | 0.099 0.026 CHEMBL1176 | CHEMBL1176 | |
| 0.008 | 0.396 | 0.038 | Histone deacetylase 9 inhibitor | 0.038 0.03 CHEMBL1176 | CHEMBL1176 | |
| 0.012 | 0.406 | 0.101 | Anesthetic local | 0.101 0.082 CHEMBL1176 | CHEMBL1176 | |
| 0.057 | 0.453 | 0.221 | Transcription factor NF kappa B inhibitor | 0.221 0.15 CHEMBL3544846 | CHEMBL3544846 | |
| 0.039 | 0.438 | 0.216 | Antiamyloidogenic | 0.153 0.143 CHEMBL1176 0.216 0.089 CHEMBL3544846 | CHEMBL3544846 | |
| 0.039 | 0.438 | 0.257 | Calpain inhibitor | 0.257 0.059 CHEMBL1176 0.237 0.078 CHEMBL3544846 | CHEMBL1176 | |
| 0.044 | 0.445 | 0.192 | Non-steroidal antiinflammatory agent | 0.18 0.088 CHEMBL1176 0.192 0.078 CHEMBL3544846 | CHEMBL3544846 | |
| 0.054 | 0.455 | 0.125 | Vanilloid 1 agonist | 0.125 0.076 CHEMBL3544846 | CHEMBL3544846 | |
| 0.01 | 0.415 | 0.102 | Mineralocorticoid receptor antagonist | 0.102 0.008 CHEMBL1176 0.067 0.016 CHEMBL3544846 | CHEMBL1176 | |
| 0.035 | 0.446 | 0.228 | Prostaglandin dehydrogenase inhibitor | 0.191 0.163 CHEMBL1176 0.228 0.139 CHEMBL3544846 | CHEMBL3544846 | |
| 0.027 | 0.455 | 0.17 | Phospholipase A2 inhibitor | 0.141 0.084 CHEMBL1176 0.17 0.06 CHEMBL3544846 | CHEMBL3544846 | |
| 0.045 | 0.484 | 0.433 | Calpain 2 inhibitor | 0.433 0.045 CHEMBL1176 0.396 0.063 CHEMBL3544846 | CHEMBL1176 | |
| 0.044 | 0.484 | 0.198 | Thyroid hormone antagonist | 0.189 0.171 CHEMBL1176 0.198 0.164 CHEMBL3544846 | CHEMBL3544846 | |
| 0.044 | 0.49 | 0.189 | Thyroid hormone beta antagonist | 0.189 0.164 CHEMBL1176 0.189 0.164 CHEMBL3544846 | CHEMBL3544846 | |
| 0.025 | 0.478 | 0.113 | Protein kinase stimulant | 0.113 0.101 CHEMBL3544846 | CHEMBL3544846 | |
| 0.008 | 0.462 | 0.17 | Monophenol monooxygenase inhibitor | 0.17 0.04 CHEMBL3544846 | CHEMBL3544846 | |
| 0.005 | 0.48 | 0.045 | HIV-1 protease inhibitor | 0.045 0.027 CHEMBL1176 0.045 0.028 CHEMBL3544846 | CHEMBL3544846 | |
| 0.01 | 0.5 | 0.094 | Purinergic P2Y2 antagonist | 0.094 0.004 CHEMBL1176 0.065 0.007 CHEMBL3544846 | CHEMBL1176 | |
| 0.042 | 0.552 | 0.134 | Sigma receptor agonist | 0.134 0.098 CHEMBL3544846 | CHEMBL3544846 | |
| 0.026 | 0.556 | 0.213 | Interleukin 5 antagonist | 0.213 0.005 CHEMBL1176 0.188 0.006 CHEMBL3544846 | CHEMBL1176 | |
| 0.006 | 0.558 | 0.22 | Dopamine transporter inhibitor | 0.22 0.004 CHEMBL1176 0.135 0.007 CHEMBL3544846 | CHEMBL1176 | |
| 0.005 | 0.558 | 0.098 | Prostaglandin antagonist | 0.098 0.018 CHEMBL1176 0.052 0.038 CHEMBL3544846 | CHEMBL1176 | |
| 0.024 | 0.578 | 0.273 | Lipoxygenase inhibitor | 0.273 0.085 CHEMBL3544846 | CHEMBL3544846 | |
| 0.004 | 0.583 | 0.06 | Prostacyclin antagonist | 0.06 0.009 CHEMBL1176 0.047 0.014 CHEMBL3544846 | CHEMBL1176 | |
| 0.004 | 0.594 | 0.124 | Neurokinin 1 antagonist | 0.124 0.005 CHEMBL1176 0.041 0.028 CHEMBL3544846 | CHEMBL1176 | |
| 0.008 | 0.601 | 0.046 | Estrogen-related receptor beta antagonist | 0.046 0.007 CHEMBL3544846 | CHEMBL3544846 | |
| 0.017 | 0.617 | 0.602 | Alpha-glucosidase inhibitor | 0.463 0.092 CHEMBL1176 0.602 0.053 CHEMBL3544846 | CHEMBL3544846 | |
| 0.033 | 0.637 | 0.212 | Transcription factor STAT inhibitor | 0.187 0.157 CHEMBL1176 0.212 0.122 CHEMBL3544846 | CHEMBL3544846 | |
| 0.005 | 0.616 | 0.63 | HIV-1 integrase (Strand Transfer) inhibitor | 0.63 0.002 CHEMBL1176 0.57 0.003 CHEMBL3544846 | CHEMBL1176 | |
| 0.006 | 0.617 | 0.119 | HIV-1 reverse transcriptase inhibitor | 0.119 0.022 CHEMBL1176 0.087 0.037 CHEMBL3544846 | CHEMBL1176 | |
| 0.002 | 0.633 | 0.117 | Estrogen receptor alpha agonist | 0.117 0.007 CHEMBL3544846 | CHEMBL3544846 | |
| 0.004 | 0.64 | 0.134 | Neurokinin antagonist | 0.134 0.006 CHEMBL1176 0.045 0.042 CHEMBL3544846 | CHEMBL1176 | |
| 0.003 | 0.647 | 0.051 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.051 0.015 CHEMBL3544846 | CHEMBL3544846 | |
| 0.009 | 0.672 | 0.446 | Topoisomerase II alpha inhibitor | 0.446 0.004 CHEMBL1176 0.434 0.004 CHEMBL3544846 | CHEMBL1176 | |
| 0.014 | 0.702 | 0.09 | Potassium channel large-conductance Ca-activated activator | 0.09 0.029 CHEMBL3544846 | CHEMBL3544846 | |
| 0.016 | 0.714 | 0.054 | Adenine nucleotide translocase inhibitor | 0.054 0.043 CHEMBL3544846 | CHEMBL3544846 | |
| 0.018 | 0.718 | 0.11 | Toll-Like receptor 4 antagonist | 0.11 0.056 CHEMBL3544846 | CHEMBL3544846 | |
| 0.006 | 0.734 | 0.09 | Topoisomerase I inhibitor | 0.09 0.079 CHEMBL3544846 | CHEMBL3544846 | |
| 0.035 | 0.764 | 0.262 | Apoptosis antagonist | 0.262 0.116 CHEMBL3544846 | CHEMBL3544846 | |
| 0.003 | 0.742 | 0.355 | Complement C3a chemotactic receptor antagonist | 0.355 0.002 CHEMBL1176 0.158 0.004 CHEMBL3544846 | CHEMBL1176 | |
| 0.004 | 0.759 | 0.827 | HIV-1 integrase (3'-Processing) inhibitor | 0.827 0.002 CHEMBL1176 0.74 0.002 CHEMBL3544846 | CHEMBL1176 | |
| 0.003 | 0.761 | 0.036 | Prostaglandin D2 antagonist | 0.036 0.009 CHEMBL1176 | CHEMBL1176 | |
| 0.01 | 0.774 | 0.345 | Bone formation stimulant | 0.343 0.013 CHEMBL1176 0.345 0.013 CHEMBL3544846 | CHEMBL3544846 | |
| 0.008 | 0.84 | 0.128 | Nitric oxide antagonist | 0.128 0.122 CHEMBL3544846 | CHEMBL3544846 | |
| 0.005 | 0.87 | 0.651 | Thioredoxin glutathione reductase inhibitor | 0.651 0.011 CHEMBL1176 0.532 0.023 CHEMBL3544846 | CHEMBL1176 | |
| 0.01 | 0.881 | 0.142 | Platelet adhesion inhibitor | 0.142 0.116 CHEMBL3544846 | CHEMBL3544846 | |
| 0.003 | 0.888 | 0.134 | Kinesin-like protein 1 inhibitor | 0.134 0.005 CHEMBL1176 0.115 0.006 CHEMBL3544846 | CHEMBL1176 | |
| 0.003 | 0.888 | 0.134 | Kinesin antagonist | 0.134 0.005 CHEMBL1176 0.115 0.006 CHEMBL3544846 | CHEMBL1176 | |
| 0.004 | 0.905 | 0.355 | Mcl-1 antagonist | 0.347 0.016 CHEMBL1176 0.355 0.015 CHEMBL3544846 | CHEMBL3544846 | |
| 0.006 | 0.91 | 0.323 | Analgesic | 0.323 0.125 CHEMBL1176 0.276 0.161 CHEMBL3544846 | CHEMBL1176 | |
| 0.004 | 0.912 | 0.231 | Estrogen receptor beta antagonist | 0.231 0.008 CHEMBL3544846 | CHEMBL3544846 | |
| 0.002 | 0.913 | 0.034 | HMG CoA reductase inhibitor | 0.034 0.024 CHEMBL1176 0.032 0.029 CHEMBL3544846 | CHEMBL1176 | |
| 0.001 | 0.919 | 0.109 | Estrogen receptor beta agonist | 0.109 0.01 CHEMBL3544846 | CHEMBL3544846 | |
| 0.002 | 0.921 | 0.155 | Estrogen agonist | 0.155 0.011 CHEMBL3544846 | CHEMBL3544846 | |
| 0.041 | 0.965 | 0.313 | Calcium channel L-type activator | 0.313 0.146 CHEMBL3544846 | CHEMBL3544846 | |
| 0.006 | 0.938 | 0.232 | Amyloid beta aggregation inhibitor | 0.232 0.064 CHEMBL3544846 | CHEMBL3544846 | |
| 0.004 | 0.94 | 0.14 | 5-Lipoxygenase inhibitor | 0.14 0.042 CHEMBL3544846 | CHEMBL3544846 | |
| 0.004 | 0.944 | 0.315 | Antioxidant | 0.315 0.056 CHEMBL3544846 | CHEMBL3544846 | |
| 0.004 | 0.946 | 0.284 | Topoisomerase II inhibitor | 0.186 0.037 CHEMBL1176 0.284 0.02 CHEMBL3544846 | CHEMBL3544846 | |
| 0.004 | 0.948 | 0.245 | Estrogen antagonist | 0.245 0.009 CHEMBL3544846 | CHEMBL3544846 | |
| 0.004 | 0.962 | 0.401 | Free radical scavenger | 0.164 0.129 CHEMBL1176 0.401 0.029 CHEMBL3544846 | CHEMBL3544846 | |
| 0.003 | 0.981 | 0.377 | Protein-tyrosine phosphatase 1B inhibitor | 0.377 0.006 CHEMBL1176 0.351 0.008 CHEMBL3544846 | CHEMBL1176 | |
| 0.004 | 0.983 | 0.406 | Protein-tyrosine phosphatase inhibitor | 0.406 0.008 CHEMBL1176 0.388 0.009 CHEMBL3544846 | CHEMBL1176 | |
| 0.004 | 0.987 | 0.623 | Cyclophilin D inhibitor | 0.623 0.024 CHEMBL1176 0.575 0.032 CHEMBL3544846 | CHEMBL1176 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |